HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hajime Maeda Hikaru Matsuda Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inoue, M. Articles by Matsuda, H. Search for Related Content PubMed PubMed Citation Articles by Inoue, M. Articles by Matsuda, H.

Ann Thorac Surg 2000;70:1615-1619
© 2000 The Society of Thoracic Surgeons

---

Original articles: general thoracic

Surgical results for small cell lung cancer based on the new TNM staging system

^a Department of Surgery, Osaka Prefectural Habikino Hospital, Osaka, Japan
^b Department of Surgery, Course of Interventional Medicine (E1), Osaka University Graduate School of Medicine, Osaka, Japan
^c Department of Surgery, National Kinki Central Hospital for Chest Diseases, Osaka, Japan
^d Department of Surgery, Toneyama National Hospital, Osaka, Japan

Address reprint requests to Dr Miyoshi, Department of Surgery, Course of Interventional Medicine (E1), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
e-mail: miyoshi{at}surg1.med.osaka-u.ac.jp

Background. Operation with combined chemotherapy has been recently recommended for very early stage of small cell lung cancer without lymph node metastasis.

Methods. A retrospective study was undertaken in 91 patients who had undergone pulmonary resection for small cell lung cancer according to the new international staging system.

Results. The 5-year overall probability of survival was 37.1%. The 5-year survival rate was 100% for p-stage 0, 56.1% for p-stage IA, 30.0% for p-stage IB, 57.1% for p-stage IIA, and 42.9% for p-stage IIB. In the p-stage IA–IIB patients who underwent a complete resection, the 5-year survival rate of the patients treated by operation with chemotherapy was better than that of patients treated by operation alone. In addition, the 5-year survival rate of the patients who had four or more courses of chemotherapy was 80.0%.

Conclusions. These results suggest that operation should be considered for p-stage IA–IIB patients and more than four courses of combined chemotherapy might be desirable in these resectable cases.

This article has been cited by other articles:

				V. Chandra, M. S. Allen, F. C. Nichols III, C. Deschamps, S. D. Cassivi, and P. C. Pairolero The Role of Pulmonary Resection in Small Cell Lung Cancer Mayo Clin. Proc., May 1, 2006; 81(5): 619 - 624. [Abstract] [Full Text] [PDF]

				M. Sakai, S. Ishikawa, T. Yamamoto, M. Onizuka, Y. Sakakibara, T. Iijima, and M. Noguchi Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy Interactive CardioVascular and Thoracic Surgery, April 1, 2005; 4(2): 118 - 122. [Abstract] [Full Text] [PDF]

				A. Spira and D. S. Ettinger Multidisciplinary Management of Lung Cancer N. Engl. J. Med., January 22, 2004; 350(4): 379 - 392. [Full Text] [PDF]

				R. J. Ginsberg Small cell lung cancer: how should we treat it? what is it? Ann. Thorac. Surg., November 1, 2000; 70(5): 1453 - 1454. [Full Text] [PDF]